<p>The National Human Genome Research Institute awarded a purchase order to Georgetown University on September 4, 2020, with a ceiling value of $12,528.00 for DNA extraction and RNA extraction services using EBV transformed lymphoblast cell lines during fiscal year 2020. Performance occurs in Washington, DC 20057. The order carries firm fixed-price pricing and ultimate completion on September 30, 2020.</p>
This is a firm fixed-price purchase order contract awarded by the National Human Genome Research Institute (NHGRI), a civilian agency within the National Institutes of Health (NIH), to Reprocell U.S.A., Inc. for $17,016.80. The contract was awarded on January 5, 2023 with a completion date of July 5, 2023. The contract supports genetic and epigenetic analysis at the transcriptome level, which is a critical component of the Comprehensive Disease Study (CDS) program's integrative research...
<p>The National Human Genome Research Institute awarded a purchase order to Eurofins Genomics LLC for $14,975.00 on December 13, 2016, with a firm fixed price for research studies. Place of performance is Bethesda, Maryland. The order was not set-aside and carries an ultimate completion date of January 11, 2021.</p>
<p>The National Human Genome Research Institute issued a $149,618.50 delivery order to Illumina, Inc., on September 1, 2017, for genetic sequencing and genomic analysis technologies.</p>
<p>Place of performance is North Bethesda, MD. The order has a firm fixed-price structure with an ultimate completion date of September 30, 2017.</p>
<p>The National Human Genome Research Institute awarded a purchase order to Qiagen, LLC for $10,456.60 on August 16, 2016, with firm fixed price, no set-aside. Place of performance is Bethesda, Maryland. The order calls for molecular diagnostics consumables and reagents, including DNA/RNA extraction kits and related laboratory supplies. Ultimate completion date is December 22, 2020.</p>
<p>The National Heart Lung and Blood Institute awarded a purchase order to Reprocell U.S.A., Inc. for DNA and RNA extraction from whole blood with a ceiling value of $73,338.90, effective April 15, 2020, and completing April 14, 2021. Work is performed at Calverton, Maryland. The order is firm fixed price with no small business set-aside.</p>
<p>The National Human Genome Research Institute awarded a purchase order to Rees Scientific Corporation valued at $4,241.54 on August 9, 2016. Work is performed in Bethesda, Maryland. The order is firm fixed price with no small business set-aside. Ultimate completion is scheduled for December 23, 2020. The source does not specify the goods or services procured.</p>
<p>The National Human Genome Research Institute awarded a purchase order to DNA Genotek Inc. valued at $8,310.00 on December 23, 2015, for DNA collection and analysis products, with final completion on December 21, 2020. Work is performed at DNA Genotek's facility in Ottawa, Ontario, Canada. The order carries firm fixed-price pricing and was issued through full and open competition with no set-aside.</p>
<p>The National Human Genome Research Institute issued a $5,450.23 delivery order to Illumina, Inc. on August 15, 2018, for genetic sequencing and genomic analysis technologies.</p>
<p>Place of performance is North Bethesda, MD. The order carries a firm fixed-price structure and an ultimate completion date of September 14, 2018.</p>
This is a $37,814 firm fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Reprocell U.S.A., Inc. The contract is for the extraction of total RNA from whole blood samples in support of research activities at the National Human Genome Research Institute (NHGRI), another NIH agency. The contract was awarded on July 10, 2020 through full and open competition, with a period of performance ending on March 31,...